CAR T cells, immunologic and cellular therapies in hematologic malignancies.
作者信息
Brentjens Renier, Davila Marco L
机构信息
Department of Medicine, Memorial Sloan Kettering Cancer Center, USA.
Department of Blood & Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, USA.
出版信息
Best Pract Res Clin Haematol. 2018 Jun;31(2):115-116. doi: 10.1016/j.beha.2018.05.001. Epub 2018 May 18.
Abstract
摘要
相似文献
1
CAR T cells, immunologic and cellular therapies in hematologic malignancies.
Best Pract Res Clin Haematol. 2018 Jun;31(2):115-116. doi: 10.1016/j.beha.2018.05.001. Epub 2018 May 18.
2
Toxicities associated with immunotherapies for hematologic malignancies.
Best Pract Res Clin Haematol. 2018 Jun;31(2):158-165. doi: 10.1016/j.beha.2018.03.004. Epub 2018 Mar 28.
3
CAR T-cell therapy: perceived need versus actual evidence.
Lancet Oncol. 2018 Oct;19(10):1259. doi: 10.1016/S1470-2045(18)30698-3. Epub 2018 Oct 1.
4
Recent Advances in CAR-T Therapy.
Cancer Control. 2024 Jan-Dec;31:10732748241263713. doi: 10.1177/10732748241263713.
5
Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors.
Clin Pharmacol Ther. 2019 Jan;105(1):71-78. doi: 10.1002/cpt.1280.
6
Chimeric antigen receptor T-cell therapy for haematological malignancies.
Med J Aust. 2020 Nov;213(9):404-406.e1. doi: 10.5694/mja2.50783. Epub 2020 Sep 20.
7
Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies.
Immunotherapy. 2020 Dec;12(18):1341-1357. doi: 10.2217/imt-2020-0181. Epub 2020 Nov 5.
8
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy.
Front Immunol. 2021 May 31;12:670286. doi: 10.3389/fimmu.2021.670286. eCollection 2021.
9
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.
J Immunother Cancer. 2018 Dec 4;6(1):137. doi: 10.1186/s40425-018-0460-5.
10
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects.
Cancer Lett. 2020 Mar 1;472:175-180. doi: 10.1016/j.canlet.2019.11.033. Epub 2019 Nov 29.
本文引用的文献
1
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866.
2
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10.
3
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
Biol Blood Marrow Transplant. 2017 Aug;23(8):1311-1319. doi: 10.1016/j.bbmt.2017.04.028. Epub 2017 May 5.
4
Current and emerging strategies for the prevention of graft-versus-host disease.
Nat Rev Clin Oncol. 2014 Sep;11(9):536-47. doi: 10.1038/nrclinonc.2014.102. Epub 2014 Jun 24.
5
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Sci Transl Med. 2014 Feb 19;6(224):224ra25. doi: 10.1126/scitranslmed.3008226.
6
Adoptive immunotherapy for cancer or viruses.
Annu Rev Immunol. 2014;32:189-225. doi: 10.1146/annurev-immunol-032713-120136. Epub 2014 Jan 9.
7
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
8
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
J Clin Invest. 2011 May;121(5):1822-6. doi: 10.1172/JCI46110. Epub 2011 Apr 11.
9
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Blood. 2010 Nov 18;116(20):4099-102. doi: 10.1182/blood-2010-04-281931. Epub 2010 Jul 28.
10
Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15178-83. doi: 10.1073/pnas.0505539102. Epub 2005 Oct 10.
Zotero 插件